Aromasin & ArimidexAlso known as: Aromatase Inhibitors (AIs)

The Problem With How Most Men Use AIs

Aromatase inhibitors are the most commonly over-prescribed compound class in the TRT space. The standard narrative on forums and in low-quality TRT clinics is to start an AI automatically when starting testosterone — the assumption being that high estrogen is inevitable and must be preemptively suppressed. This is clinically incorrect and causes more harm than it prevents.

Estradiol (E2) is not testosterone's enemy. It is a critical hormone in the male physiology responsible for:

• Bone density maintenance — estrogen is the primary driver of bone mineralization in men, more so than testosterone itself
• Cardiovascular protection — men with estradiol in the normal range have better cardiovascular outcomes than men with suppressed estradiol
• Sexual function — libido and erectile function in men require estrogen in an appropriate range; too low is as problematic as too high
• Cognitive function — estrogen receptors are densely expressed in the hippocampus and prefrontal cortex; crashed E2 causes brain fog, depression, and mood instability
• Joint lubrication — estrogen supports synovial fluid production; men with low E2 report joint pain that is often misattributed to other causes

An AI should be introduced only when: (1) sensitive E2 testing confirms elevation above the individual's symptom threshold, and (2) symptoms of high estrogen are actually present. Initiating an AI based on total testosterone dose alone, without lab confirmation, is poor practice.

Arimidex (Anastrozole): The Reversible AI

Anastrozole (Arimidex) is a non-steroidal, reversible aromatase inhibitor. It works by competing with testosterone and androstenedione for the active site of the aromatase enzyme (CYP19A1). When anastrozole is present, it occupies the enzyme binding site and prevents the conversion of androgens to estrogens. Crucially, this is reversible — when anastrozole is cleared from the body, aromatase activity resumes.

Dosing

Starting dose: 0.25mg every 3 days (E3D), titrated based on sensitive E2 levels checked 4–6 weeks after initiation. Most men on 100–200mg testosterone/week find 0.25–0.5mg E3D adequate if an AI is needed at all. Some sensitive men require as little as 0.125mg E3D.

Key caution: anastrozole dosing is notoriously difficult to titrate because individual aromatase activity varies enormously. A dose that barely moves one man's E2 will crash another man's estrogen. Start low and titrate based on labs and symptoms.

Estrogen Rebound Risk

Because anastrozole is reversible, stopping it abruptly — particularly from higher doses — can result in a temporary spike in aromatase activity and estrogen as the enzyme rebounds. This typically resolves within 1–2 weeks but can be symptomatic (water retention, mood changes, sensitivity). Tapering the dose when discontinuing is advisable if you have been taking it for more than 4–6 weeks.

Aromasin (Exemestane): The Irreversible AI

Exemestane (Aromasin) is a steroidal, irreversible aromatase inactivator — often called a "suicidal AI." When exemestane binds to the aromatase enzyme, it permanently inactivates it. The enzyme molecule must be replaced by newly synthesized aromatase before estrogen production can resume in that tissue. This has two important clinical implications:

• No rebound on discontinuation: Because the inactivated enzymes must be replaced by new synthesis (which takes days to weeks), stopping exemestane does not cause the same acute estrogen rebound that stopping anastrozole can
• Less titratable: The permanent inactivation means dosing effects persist longer than with anastrozole, making it harder to fine-tune estrogen levels in real time

Dosing

Starting dose: 6.25mg every 3 days (E3D), taken with a fatty meal to improve absorption (exemestane is a steroidal compound and is fat-soluble). Standard range is 6.25–25mg E3D depending on aromatization rate and response. Many practitioners prefer exemestane precisely because there is no rebound risk when cycling on and off compounds.

Choosing Between Aromasin and Arimidex

Both compounds are clinically effective. The choice depends on individual circumstances:

• Choose Arimidex if: You need fine-grained dose titration, you are new to AI use and want to start with the most studied compound, or you are working with a physician who prefers anastrozole
• Choose Aromasin if: You are cycling compounds on and off and want to avoid rebound estrogen spikes, or you have previously experienced rebound symptoms with anastrozole, or you prefer a steroidal compound that also has mild androgenic activity

Monitoring and Adjusting AI Dose

Sensitive estradiol (LC-MS/MS method, not standard immunoassay) should be checked 4–6 weeks after any AI dose change. Target range for most men on TRT: 20–40 pg/mL, with individual symptom correlation. Symptoms of over-suppression (crashed E2): joint pain, depression, low libido despite adequate testosterone, erectile dysfunction, brain fog, lethargy. If these appear, reduce or stop the AI immediately.

The T:E2 ratio (total testosterone in ng/dL divided by sensitive E2 in pg/mL) is a useful heuristic — aim for 10:1 to 20:1. A man at 700 ng/dL testosterone and 35 pg/mL E2 has a ratio of 20:1, which is generally well-tolerated.

Sourcing and Verification

Both anastrozole and exemestane require a prescription in the United States. They are available through licensed TRT clinics, compounding pharmacies, and international pharmacies depending on jurisdiction. Compounded anastrozole and exemestane are widely used in TRT clinics and are generally considered equivalent to brand-name formulations in clinical practice. As with all compounded medications, request COA documentation confirming potency and purity from the compounding pharmacy.